Journal
NEUROBIOLOGY OF AGING
Volume 33, Issue 9, Pages 2210-2214Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2011.08.009
Keywords
Mitochondrial DNA; mtDNA deletions; Alzheimer's disease; Aging; Mitochondrial dysfunction
Categories
Funding
- Alzheimer's Research UK
- Newcastle University Centre for Brain Ageing and Vitality
- BBSRC
- EPSRC
- ESRC
- MRC as part of the cross-council Lifelong Health and Wellbeing Initiative
- Medical Research Council [G0900652, MC_G0802536, G1100540, G0700718, G0700718B, G0800674, G0400074, G0502157] Funding Source: researchfish
- MRC [G0800674, MC_G0802536, G1100540, G0502157, G0900652, G0700718, G0400074] Funding Source: UKRI
Ask authors/readers for more resources
Alzheimer's disease (AD) is the most common form of dementia, increasing in prevalence with age. Most patients who develop AD have an unknown cause, but characteristic neuropathological features include the deposition of extracellular amyloid beta and of intraneuronal hyperphosphorylated tau protein. Researchers have previously implicated mitochondrial dysfunction in AD. We previously showed an increase in neurons displaying a mitochondrial biochemical defect-cytochrome-c oxidase (COX) deficiency-in the hippocampus in patients with sporadic AD compared with age-matched controls. COX deficiency is well described as a marker of mitochondrial (mt) DNA dysfunction. This present study analyzed the mtDNA in single neurons from both COX normal and COX-deficient cells. Analysis of the mtDNA revealed that COX deficiency is caused by high levels of mtDNA deletions which accumulate with age. Future research is needed to clarify the role mtDNA deletions have in normal aging and investigate the relationship between mtDNA deletions and the pathogenesis of sporadic AD. (C) 2012 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available